occurs in has participant quality has disease treated with drug INTERFERON ALFA-2A GEMCITABINE CYTARABINE MITOXANTRONE HYDROCHLORIDE BETAXOLOL DOXORUBICIN FLECAINIDE ALDESLEUKIN SOTALOL ANASTROZOLE BICALUTAMIDE DOCETAXEL CAPECITABINE RITUXIMAB TRASTUZUMAB IMATINIB DAPTOMYCIN ERLOTINIB LENALIDOMIDE NELARABINE DASATINIB CABAZITAXEL CARFILZOMIB female breast cancer heart conduction disease prostate cancer prostate carcinoma chronic lymphocytic leukemia hypertension lymphocytic choriomeningitis breast cancer pancreatic cancer ovarian cancer hairy cell leukemia dermatofibrosarcoma protuberans renal cell carcinoma aggressive systemic mastocytosis acute T cell leukemia chronic myeloid leukemia myeloid leukemia Ritter's disease acute myeloid leukemia colorectal cancer multiple myeloma Elderly Adult dyspnea AE 10013963 10013968 NCIt: C2998 SIDER: C0013404 呼吸困难 UMLS CUI: C0013404 MedDRA: 10013968 is for "dyspnoea"; MedDRA: 10013963 is for "dyspnea". dyspnoea AE is an abnormal respiration AE debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations, shortness of breath, air hunger dyspnoea AE SS, YH WEB: http://en.wikipedia.org/wiki/Dyspnoea HPO: HP_0002094 CTCAE: E13368 abnormal respiration AE AE severity G1 AE severity G2 AE severity G3 AE severity G4 AE severity G5